Must be done by tonight at 1130 !!!! No plagiarism Write a 2- to 3-page paper

profileLoslocos21
CaseStudyweek2Pharm.docx

Case Study

Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following:

· glipizide 10 mg po daily

· HCTZ 25 mg daily

· atenolol 25 mg po daily

· hydralazine 25 mg qid

· simvastatin 80 mg daily

· verapamil 180 mg CD daily

· Review the Resources for this module and consider the impact of potential pharmacotherapeutics for cardiovascular disorders introduced in the media piece.

· Review the case study assigned by your Instructor for this Assignment.

· Select one the following factors: genetics, gender, ethnicity, age, or behavior factors.

· Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes.

· Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy.

· Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient.

Cas

e

S

tudy

Patient

CB

has

a

hist

ory

of

strokes.

The

patient

has

been

diagnosed

with

type

2

diabetes,

hypertension,

and

hyperlipidemia.

Drugs

currently

prescribed

include

the

following:

·

glipizide

10

mg

po

daily

·

HCTZ

25

mg

daily

·

atenolol

25

mg

po

daily

·

hydralazine

25

mg

qid

·

simvastatin

80

mg

daily

·

verapamil

180

mg

CD

daily

·

Review the Resources for this module and consider the impact of potential

pharmacotherapeutics for cardiovascular disorders introduced in the media

piece.

·

Review the case study assigned by your Instructor for t

his Assignment.

·

Select one the following factors: genetics, gender, ethnicity, age, or behavior

factors.

·

Reflect on how the factor you selected might influence the patient’s

pharmacokinetic and pharmacodynamic processes.

·

Consider how changes in the pharmacokinetic and pharmacodynamic processes

might impact the patient’s recommended drug therapy.

·

Think about h

ow you might improve the patient’s drug therapy plan based on the

pharmacokinetic and pharmacodynamic changes. Reflect on whether you would

modify the current drug treatment or provide an alternative treatment option for

the patient.

Case Study

Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension,

and hyperlipidemia. Drugs currently prescribed include the following:

 glipizide 10 mg po daily

 HCTZ 25 mg daily

 atenolol 25 mg po daily

 hydralazine 25 mg qid

 simvastatin 80 mg daily

 verapamil 180 mg CD daily

 Review the Resources for this module and consider the impact of potential

pharmacotherapeutics for cardiovascular disorders introduced in the media

piece.

 Review the case study assigned by your Instructor for this Assignment.

 Select one the following factors: genetics, gender, ethnicity, age, or behavior

factors.

 Reflect on how the factor you selected might influence the patient’s

pharmacokinetic and pharmacodynamic processes.

 Consider how changes in the pharmacokinetic and pharmacodynamic processes

might impact the patient’s recommended drug therapy.

 Think about how you might improve the patient’s drug therapy plan based on the

pharmacokinetic and pharmacodynamic changes. Reflect on whether you would

modify the current drug treatment or provide an alternative treatment option for

the patient.